Biomedical HIV Prevention Research: HIVR4P Conference Highlights
A robust list of articles summarizing the status of biomedical HIV prevention research, as presented at the 2018 HIV Research for Prevention Conference (HIVR4P 2018), have been compiled by the New England AETC in Highlights from the 2018 HIVR4P Conference.
The summaries were brought to our attention by the AETC NCRC and include HIVR4P website links (to posters, webinars and daily overviews) along with articles by AIDSMAP, NIAID, AVAC, TheBodyPRO, and the HIV Treatment Bulletin.
Here are just a few:
- Viral suppression among MSM in Atlanta will need to increase substantially in order to achieve a marked reduction in new HIV infections in the city (see NIAID: Final HIV Prevention Research Highlights from HIVR4P 2018)
- The molecule broadly neutralising antibodies (bNAbs), natural entry inhibitors that might prevent HIV from attaching to and infecting cells, are being studied as potential new treatment and PrEP options (see AIDSMap's Conference Bulletin and more on the AIDSMap HIVr4P webpage)
- Four new PrEP options under study that are not a daily pill. (The BodyPRO provides an easy-to-read review in Four New Approaches to PrEP in Development That Aren’t a Daily Pill)